naltrexone protective_against relapse
Evidence from:
primary |
all sources
Evidence (4 sources)
Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity.
(2017)
PMID:28134463
cited
NTX treatment relative to placebo led to a clinically significant reduction in relapse
confidence: 0.90
Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity.
(2017)
PMID:28134463
cited
A/G or G/G carriers took significantly longer to relapse (p = 0.014) than A/A carriers
confidence: 0.95
Naltrexone, a MOR antagonist, is also able to reduce relapse to heavy drinking...
confidence: 0.95
Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.
(2012)
PMID:22954510
cited
naltrexone ... increases time to first relapse and yields lower relapse rates
confidence: 0.94